This consequently dampens insulin signaling and therefore targeting this interaction puts forth potential therapeutic strategies to normalize aberrant insulin signaling and metabolism within the skeletal muscle as is observed in obesity and diabetes. This evidence concerns the gene INS and obesity disorder.